AU5010196A - Therapeutic benzoxazoles - Google Patents

Therapeutic benzoxazoles

Info

Publication number
AU5010196A
AU5010196A AU50101/96A AU5010196A AU5010196A AU 5010196 A AU5010196 A AU 5010196A AU 50101/96 A AU50101/96 A AU 50101/96A AU 5010196 A AU5010196 A AU 5010196A AU 5010196 A AU5010196 A AU 5010196A
Authority
AU
Australia
Prior art keywords
benzoxazoles
therapeutic
therapeutic benzoxazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50101/96A
Inventor
Darryl Gene Cleary
Michael Cory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU5010196A publication Critical patent/AU5010196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
AU50101/96A 1995-03-15 1996-03-14 Therapeutic benzoxazoles Abandoned AU5010196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9505191.8A GB9505191D0 (en) 1995-03-15 1995-03-15 Therapeutic benzoxazoles
GB9505191 1995-03-15
PCT/GB1996/000595 WO1996028443A1 (en) 1995-03-15 1996-03-14 Therapeutic benzoxazoles

Publications (1)

Publication Number Publication Date
AU5010196A true AU5010196A (en) 1996-10-02

Family

ID=10771219

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50101/96A Abandoned AU5010196A (en) 1995-03-15 1996-03-14 Therapeutic benzoxazoles

Country Status (3)

Country Link
AU (1) AU5010196A (en)
GB (1) GB9505191D0 (en)
WO (1) WO1996028443A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759842A (en) * 1996-10-24 1998-06-02 Merck & Co., Inc. In vitro HIV integrase inhibitors
US5939414A (en) * 1996-10-31 1999-08-17 Merck & Co., Inc. Benzodiazepine hydrazide derivatives as inhibitors of HIV integrase
US5858738A (en) * 1996-11-07 1999-01-12 Merck & Co., Inc. Ermophilane sesquiterpenoids as HIV intergrase inhibitors
US6124327A (en) * 1997-07-29 2000-09-26 Merck & Co., Inc. HIV integrase inhibitors
US6403347B1 (en) 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
US6110716A (en) * 1998-02-04 2000-08-29 Merck & Co., Inc. HIV integrase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387512A (en) * 1991-06-07 1995-02-07 Merck & Co. Inc. Preparation of 3-[z-benzoxazol-2-yl)ethyl]-5-(1-hydroxyethyl)-6-methyl-2-(1H)-pyridinone by biotransformation

Also Published As

Publication number Publication date
WO1996028443A1 (en) 1996-09-19
GB9505191D0 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
AU6282196A (en) Therapeutic glove
AU5478496A (en) Therapeutic amides
AU7246596A (en) Risc86 instruction set
AU4006495A (en) Vibrating catheter
AU5586398A (en) Submersive therapy apparatus
AU5268696A (en) Novel compounds and methods for therapy
AU5457096A (en) Gene-transfer-mediated angiogenesis therapy
AU4780596A (en) Hemi-wheeled walker
AU2805195A (en) Therapeutic compounds
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU5859996A (en) Diaper
AU5252598A (en) Multi-trauma therapeutic machine
EP0747032A3 (en) Portable sauna
AU5119296A (en) Magnetotherapy unit
AU5315096A (en) 19-oxygenated steroids as therapeutic agents
AU5010196A (en) Therapeutic benzoxazoles
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AUPN727595A0 (en) Therapeutic compositions
AU6171196A (en) Therapeutic uses of ta99
AU5011296A (en) Fibre treatment
AU5506996A (en) Sunbed
AU7190496A (en) Therapeutic compositions
AU679162B3 (en) Therapeutic compositions
AU7573296A (en) Bandage
AU4726796A (en) Massage system